Antenatal screening for carriers of hepatitis B virus
- 4 November 1995
- Vol. 311 (7014) , 1178-1179
- https://doi.org/10.1136/bmj.311.7014.1178
Abstract
Britain needs a standardised nationwide universal screening programme Acute hepatitis B is becoming much less common in Britain now that blood and blood products are safe, health care staff are being vaccinated, infectious health care workers are being steered away from procedures that could transmit the virus, drug misusers have needle exchange schemes, and sexually active people have counselling and condoms. The current morbidity and mortality from hepatitis B mostly result from the chronic carrier state,1 and the prevention of persistent infection must be central to any strategy to control the virus and its effects. The probability that infection with hepatitis B will become persistent decreases with the age at which infection occurs. Between 60% and 90% of babies born to the most infectious mothers (those positive for hepatitis B e antigen) become carriers if infected perinatally, whereas this happens to less than 10% of those people infected as adults.1 2 3 Perinatal infection can be prevented by prompt administration of immune prophylaxis at birth,4 5 and the prevention of perinatal infection in this way will have a substantial impact on the numbers of carriers in the future. The Netherlands is one of Britain's closest neighbours in Europe, and its population includes immigrants from other …Keywords
This publication has 7 references indexed in Scilit:
- Programme for preventing perinatal hepatitis B infection through screening of pregnant women and immunisation of infants of infected mothers in the Netherlands, 1989-92BMJ, 1995
- Proposal for routine antenatal screening at 14 weeks for hepatitis B surface antigenBMJ, 1995
- Screening for HBsAg in pregnant women: a cost analysis of the universal screening policy in the province of Quebec.1991
- Success of a program of routine prenatal screening for hepatitis B surface antigen: the first 2 years.1990
- Retrospective study of HIV, hepatitis B, and HTLV-I infection at a London antenatal clinicThe Lancet, 1990
- PREVENTION OF THE HBsAg CARRIER STATE IN NEWBORN INFANTS OF MOTHERS WHO ARE CHRONIC CARRIERS OF HBsAg AND HBeAg BY ADMINISTRATION OF HEPATITIS-B VACCINE AND HEPATITIS-B IMMUNOGLOBULINThe Lancet, 1984
- Efficacy of Hepatitis B Immune Globulin for Prevention of Perinatal Transmission of the Hepatitis B Virus Carrier State: Final Report of A Randomized Double–Blind, Placebo–Controlled TrialHepatology, 1983